NOVACTA BIOSYSTEMS LTD innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	WIPO (World Intellectual Property Organization)	15
#2	EPO (European Patent Office)	13
#3	United Kingdom	12
#4	Canada	10
#5	China	8
#6	Mexico	7
#7	EAPO (Eurasian Patent Organization)	6
#8	Israel	6
#9	Australia	5
#10	Brazil	5
#11	Republic of Korea	5
#12	New Zealand	4
#13	United States	4
#14	Singapore	3
#15	Taiwan	3
#16	Colombia	1
#17	Serbia	1
#18	South Africa	1

#	Technology
#1	Therapeutic chemical compounds
#2	Medical preparations
#3	Peptides
#4	Microorganisms
#5	Climate change adaptation technologies
#6	Fermentation

Publication	Filing date	Title
EA024792B1	2012-11-16	Polymyxin derivatives
GB201213434D0	2012-07-27	The use of type-B lantibiotic-based compounds having antimicrobial activity
WO2012007711A1	2011-07-12	Formulation comprising a type b lantibiotic
CA2789164A1	2011-02-01	Lantibiotic salts
GB201013507D0	2010-08-11	Compounds
GB201013511D0	2010-08-11	Salts
GB201013509D0	2010-08-11	Compounds
GB201013513D0	2010-08-11	Formulations
GB201013508D0	2010-08-11	Compounds
GB201001688D0	2010-02-02	Compounds
KR20110122139A	2010-02-02	Actagardine derivatives
BRPI1011488A2	2010-01-12	deoxyactagardine derivatives
CN102348718A	2010-01-12	Deoxyactagardine derivatives
GB0900599D0	2009-01-14	Treatment
GB0714029D0	2007-07-18	Lantibiotic-based compounds having antimicrobial activity
GB0714030D0	2007-07-18	The use of type-B lantibiotic-based compounds having antimicrobial activity
CA2623624A1	2006-09-26	Variants of the lantibiotic mersacidin and their use
US2007117749A1	2006-09-25	F3W variants of the lantibiotic mersacidin and its use
GB0600928D0	2006-01-17	Improvements relating to lantibiotics
GB0406870D0	2004-03-26	Improvements relating to the production of lantibiotics